Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

作者: M. Michaud , I. Martins , A. Q. Sukkurwala , S. Adjemian , Y. Ma

DOI: 10.1126/SCIENCE.1208347

关键词:

摘要: Antineoplastic chemotherapies are particularly efficient when they elicit immunogenic cell death, thus provoking an anticancer immune response. Here we demonstrate that autophagy, which is often disabled in cancer, dispensable for chemotherapy-induced death but required its immunogenicity. In response to chemotherapy, autophagy-competent, not autophagy-deficient, cancers attracted dendritic cells and T lymphocytes into the tumor bed. Suppression of autophagy inhibited release adenosine triphosphate (ATP) from dying cells. Conversely, inhibition extracellular ATP-degrading enzymes increased pericellular ATP autophagy-deficient tumors, reestablished recruitment cells, restored chemotherapeutic responses only immunocompetent hosts. Thus, essential concentrations improve efficacy antineoplastic disabled.

参考文章(73)
Thomas A. Ferguson, Jayoung Choi, Douglas R. Green, Armed response: how dying cells influence T-cell functions Immunological Reviews. ,vol. 241, pp. 77- 88 ,(2011) , 10.1111/J.1600-065X.2011.01006.X
P. Chiozzi, S. Falzoni, O. R. Baricordi, C. Mutini, A. Morelli, P. Ricciardi-Castagnoli, G. Collo, F. Di Virgilio, D. Ferrari, Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. Journal of Immunology. ,vol. 163, pp. 1958- 1965 ,(1999)
Lorenzo Galluzzi, Naoufal Zamzami, Thibault de La Motte Rouge, Christophe Lemaire, Catherine Brenner, Guido Kroemer, Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis. ,vol. 12, pp. 803- 813 ,(2007) , 10.1007/S10495-007-0720-1
Theocharis Panaretakis, Oliver Kepp, Ulf Brockmeier, Antoine Tesniere, Ann-Charlotte Bjorklund, Daniel C Chapman, Michael Durchschlag, Nicholas Joza, Gérard Pierron, Peter van Endert, Junying Yuan, Laurence Zitvogel, Frank Madeo, David B Williams, Guido Kroemer, Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death The EMBO Journal. ,vol. 28, pp. 578- 590 ,(2009) , 10.1038/EMBOJ.2009.1
Sophie Pattingre, Amina Tassa, Xueping Qu, Rita Garuti, Xiao Huan Liang, Noboru Mizushima, Milton Packer, Michael D. Schneider, Beth Levine, Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy Cell. ,vol. 122, pp. 927- 939 ,(2005) , 10.1016/J.CELL.2005.07.002
Eugenia Morselli, Lorenzo Galluzzi, Oliver Kepp, Guillermo Mariño, Mickael Michaud, Ilio Vitale, Maria Chiara Maiuri, Guido Kroemer, Oncosuppressive functions of autophagy. Antioxidants & Redox Signaling. ,vol. 14, pp. 2251- 2269 ,(2011) , 10.1089/ARS.2010.3478
I Martins, O Kepp, F Schlemmer, S Adjemian, M Tailler, S Shen, M Michaud, L Menger, A Gdoura, N Tajeddine, A Tesniere, L Zitvogel, G Kroemer, Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene. ,vol. 30, pp. 1147- 1158 ,(2011) , 10.1038/ONC.2010.500
Marco E. Bianchi, HMGB1 loves company Journal of Leukocyte Biology. ,vol. 86, pp. 573- 576 ,(2009) , 10.1189/JLB.1008585
Lionel Apetoh, François Ghiringhelli, Antoine Tesniere, Alfredo Criollo, Carla Ortiz, Rosette Lidereau, Christophe Mariette, Nathalie Chaput, Jean-Paul Mira, Suzette Delaloge, Fabrice André, Thomas Tursz, Guido Kroemer, Laurence Zitvogel, The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy Immunological Reviews. ,vol. 220, pp. 47- 59 ,(2007) , 10.1111/J.1600-065X.2007.00573.X
Robin Mathew, Eileen White, Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night Current Opinion in Genetics & Development. ,vol. 21, pp. 113- 119 ,(2011) , 10.1016/J.GDE.2010.12.008